Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2020-08-03 2019-11-11
Drug Identification Number 02049473 02049473
Brand name NOVAHISTINE DH NOVAHISTINE DH
Common or Proper name Novahistine DH Novahistine DH
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Strength(s) 10MG 1.7MG 10MG 1.7MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 100ml 100ml
ATC code R05DA R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-06-30 2020-06-30
Actual discontinuation date 2020-07-10
Remaining supply date 2020-06-30 2020-06-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments